CGPH Banque d’affaires
Strategy & Cross-Border Growth

The ECB Rate Is Not Your Cost of Capital: Three Prices Boards Must Separate Before 10 September

The policy rate matters. But companies do not borrow from a headline. They borrow through markets and institutions that reprice risk, maturity, collateral, optionality and execution in different ways.

September 7, 2026By CGPH Banque d’affaires
The ECB Rate Is Not Your Cost of Capital: Three Prices Boards Must Separate Before 10 September

The ECB Rate Is Not Your Cost of Capital: Three Prices Boards Must Separate Before 10 September

The policy rate matters. But companies do not borrow from a headline. They borrow through markets and institutions that reprice risk, maturity, collateral, optionality and execution in different ways.

The European Central Bank is due to publish its next monetary-policy decision on 10 September. The temptation is to reduce the week to one question: will the Governing Council move rates, and by how much?

For boards deciding whether to refinance, acquire, invest or raise capital, that is the wrong level of resolution. A policy decision can move the financial system without moving every company’s executable cost in the same direction or at the same speed. The more useful task is to separate three prices that are often discussed as if they were one: the central-bank policy rate, the market price of money and the company-specific price of capital.

The latest available evidence already shows why the distinction matters. The ECB reported that the composite cost of new borrowing for euro-area corporations was broadly unchanged at 3.80% in July. Yet the underlying rates differed by loan size and fixation period. Loans above €1 million with a floating rate or an initial fixation of up to three months averaged 3.49%; those with a fixation of more than three months and up to one year averaged 3.84%; loans with a fixation over ten years averaged 3.73%.

Those figures are system-level observations, not quotations available to a particular company. Their dispersion is the point. Even before adding borrower risk, fees, covenants and collateral, there is no single corporate borrowing rate.

The meeting is a catalyst, not the whole financing market

The policy rate is the first price. It anchors very short-term money and influences the curve through expectations about inflation, growth and future decisions. It is visible, authoritative and easy to place in a board paper.

It is also only one input.

The account of the ECB’s July meeting showed that market participants and surveyed monetary analysts did not hold identical expectations for the policy path. Markets continued to price further tightening, while the Survey of Monetary Analysts reflected a more limited path. The difference is not a forecasting curiosity. It means that some market rates can move before the Governing Council acts, because expectations have already been incorporated into prices.

A company waiting for a policy announcement may therefore discover that the relevant reference rate, swap curve or bond yield moved earlier. It may also discover that the central-bank decision was widely anticipated and produces less repricing than the headline suggests.

The first discipline is to avoid treating the meeting date as the only decision date. A financing market is continuously repriced; the policy announcement is one event within that process.

The second price is the market’s term structure

Most material corporate financings do not consist of an overnight risk-free rate. They have a maturity, a currency, a fixed or floating basis, an amortisation profile and, often, an embedded option.

That creates the second price: the market price of money for the relevant duration and structure. A floating-rate loan may reset from a short-term reference rate. A fixed-rate loan or bond embeds expectations across a longer horizon. A hedge changes exposure but brings its own tenor, basis, liquidity, documentation and break-cost considerations. Cross-border financing can add currency and jurisdictional layers.

The shape of the curve can therefore matter as much as the direction of the policy rate. If longer-term rates have already risen because markets expect persistent inflation or larger risk premia, a small policy move may not improve the economics of fixed-rate capital. Conversely, a policy increase does not mechanically mean that every point on the curve rises by the same amount.

Boards should ask which part of the curve the company is actually buying. “Rates are up” is not a financing analysis. Neither is “the ECB may pause.” The relevant question is whether the company needs short-dated liquidity, long-dated certainty, refinancing flexibility or protection against a specific cash-flow exposure—and what the market currently charges for that combination.

The third price belongs to the company

Reference rates do not produce an executable financing on their own. The company pays a credit spread and often fees; it accepts documentation, security, information duties and restrictions; it gives the capital provider a defined position in the downside.

This is the third price, and it is the one that matters most to the decision.

The ECB’s July bank lending survey reported a moderate tightening of credit standards for firms in the second quarter: the net balance was 7%, meaning the difference between banks reporting tighter standards and those reporting easier standards. Banks expected a further net tightening in the third quarter, with a net balance of 5%. The survey also reported tighter overall terms and conditions, driven mainly by higher lending rates, and higher rejection rates across borrower groups.

The companion survey of companies adds the borrower’s perspective. The net balance of firms reporting an increase in bank-loan rates was 42% in the second quarter, up from 26% in the previous quarter. The net balance was 31% for increases in other financing costs and 10% for higher collateral requirements.

These figures are the differences between firms reporting increases and those reporting decreases, not the shares of all companies experiencing a given condition. But together they show that transmission occurs through price and non-price channels. A facility can appear acceptable on margin and still become strategically expensive through shorter maturity, tighter covenants, additional collateral, lower committed availability or reduced freedom to invest and distribute cash.

The company-specific price is therefore not the coupon plus a footnote. It is the full package of cash cost, control rights, execution certainty and resilience under stress.

A lower headline rate can coexist with a harder financing

The apparent contradiction disappears once the three prices are separated.

A policy rate can be unchanged while banks tighten credit standards because perceived borrower or sector risk has increased. A market reference rate can fall while a company’s credit spread widens. A headline coupon can decline while fees, security or amortisation make the all-in package more demanding. A committed facility can become less useful if borrowing-base eligibility or covenant headroom contracts when the operating plan weakens.

This is particularly relevant for companies exposed to energy costs, trade disruption, cyclical demand or large investment programmes. The July lending survey found the most pronounced tightening in the car industry and energy-intensive manufacturing. It also reported stronger tightening for long-term than short-term corporate loans during the second quarter.

The implication is not that such companies cannot finance. It is that timing and structure should be tested against the risk lens of the capital provider, not only against a central case in the company’s model.

The board should compare structures in the same downside

Financing discussions often compare a floating-rate bank loan in a cautious case, a fixed-rate bond in a base case and minority equity in an optimistic growth case. That can make each instrument appear to answer a different company.

A defensible comparison holds the operating scenarios constant.

In the base case, how much cash remains after interest, fees, amortisation, tax, working capital and essential investment? In a downside case, what reprices, what covenant headroom remains and which decisions require consent? If rates stay higher for longer, can the company still fund the actions that protect competitiveness? If rates fall, what is the cost of prepayment, refinancing or breaking a hedge? If the company needs additional capital, does the first transaction preserve or restrict that option?

The same discipline applies across borders. A seemingly cheaper currency can introduce FX volatility. A foreign lender can expand capacity while adding governing-law, security, tax or execution requirements that must be assessed by the relevant qualified advisers. A local facility can be operationally simple but concentrated in one funding relationship.

The objective is not to identify a universally cheapest instrument. It is to identify which structure remains coherent when the path differs from the forecast.

Five variables deserve their own line in the decision paper

The first is the reference basis: which rate or curve drives the cash cost, and when does it reset? The second is the credit component: how can spread, fees or availability change as performance and leverage change? The third is maturity: when does the company lose optionality if refinancing markets are difficult? The fourth is control: what covenants, security, consent rights and reporting duties accompany the capital? The fifth is the next transaction: does today’s structure leave room for an acquisition, capex programme, dividend, follow-on raise or strategic sale?

These variables interact. A longer maturity may justify a higher visible price because it protects execution certainty. A cheaper floating structure may be appropriate where cash flows absorb volatility and prepayment flexibility matters. Equity may remove contractual debt service while changing governance and future value participation. The board’s job is to price those differences explicitly rather than hide them inside a blended percentage.

The decision on 10 September is not the company’s decision

The ECB will decide for the euro area. Each board must decide for one balance sheet.

That decision begins with a translation: from policy rate, to market curve, to executable company terms, and then into cash flow, control and strategic flexibility. A company that performs this work can respond to the meeting without being ruled by it. A company that does not may mistake a macroeconomic headline for a financing offer.

The policy rate is important because it changes the environment. The cost of capital is important because it changes the company. They should never be confused.

References and further reading

This article is provided for general information only. It does not constitute investment, financing, legal, tax, accounting, regulatory, hedging, valuation or transaction advice, and it is not a recommendation to borrow, refinance or select any financing structure. Terms and availability depend on the company, market conditions, transaction-specific diligence and the independent decisions of capital providers and their advisers.